Provided by Tiger Fintech (Singapore) Pte. Ltd.

Biohaven Pharmaceutical Holding Co Ltd.

14.46
+0.07000.49%
Post-market: 14.460.00000.00%19:08 EDT
Volume:2.79M
Turnover:40.10M
Market Cap:1.48B
PE:-1.57
High:14.63
Open:14.48
Low:13.87
Close:14.39
Loading ...

Biohaven Price Target Maintained With a $61.00/Share by RBC Capital

Dow Jones
·
04 Mar

Deutsche Bank Cuts Biohaven Price Target to $60 From $65, Maintains Buy Rating

MT Newswires Live
·
04 Mar

Biohaven Ltd : Bernstein Cuts Target Price to $57 From $73

THOMSON REUTERS
·
04 Mar

Biohaven Ltd. (BHVN) Gets a Buy from RBC Capital

TIPRANKS
·
04 Mar

BUZZ-U.S. STOCKS ON THE MOVE-Melco Resorts, Chipotle, Allegro

Reuters
·
03 Mar

BUZZ-Biohaven slides on wider-than-expected quarterly loss

Reuters
·
03 Mar

Biohaven's Q4 Non-GAAP Net Loss Widens

MT Newswires Live
·
03 Mar

Earnings Flash (BHVN) Biohaven Posts Q4 Total Operating Expenses $189.9M

MT Newswires Live
·
03 Mar

Biohaven reports ‘positive’ data from study of BHV-1300

TIPRANKS
·
03 Mar

Biohaven Ltd - Bhv-1300 Safe and Well Tolerated in Phase 1 Studies

THOMSON REUTERS
·
03 Mar

Biohaven Reports Positive Degrader Data Achieving > 80% SUSTAINED REDUCTIONS IN TOTAL IGG WITH POTENTIAL FIRST-IN-CLASS BHV-1300

THOMSON REUTERS
·
03 Mar

Biohaven Reports Positive Degrader Data Achieving > 80% Sustained Reductions in Total IgG with Potential First-in-Class BHV-1300

PR Newswire
·
03 Mar

Biohaven Q4 Profit From Operations USD -189.931 Million

THOMSON REUTERS
·
03 Mar

Biohaven Q4 Basic EPS USD -1.85

THOMSON REUTERS
·
03 Mar

FOCUS-Next generation weight loss drugs aim to save muscle

Reuters
·
19 Feb

Analysts Have Conflicting Sentiments on These Healthcare Companies: Medtronic (MDT), Biohaven Ltd. (BHVN) and Arvinas Holding Company (ARVN)

TIPRANKS
·
12 Feb

Why Biohaven (BHVN) Stock Is Rallying Today

Insider Monkey
·
12 Feb

Biohaven Shares up 7.3% as FDA Grants Priority Review Status for Brain Disorder Drug

THOMSON REUTERS
·
11 Feb

BUZZ-Biohaven rises as FDA grants priority review status for brain disorder drug

Reuters
·
11 Feb

Sector Update: Health Care Stocks Mixed Premarket Tuesday

MT Newswires Live
·
11 Feb